首页> 外文期刊>Nephron >Catheter-related bacteremia in hemodialysis: which preventive measures to take?
【24h】

Catheter-related bacteremia in hemodialysis: which preventive measures to take?

机译:血液透析中与导管相关的菌血症:应采取哪些预防措施?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The use of tunneled hemodialysis catheters as definitive vascular access is becoming increasingly more widespread, reaching 25% of all dialysis patients in some countries. The rate of infectious morbidity and mortality is much higher when catheters are used than when patients are dialyzed through grafts or native fistulas, and it is generally agreed that implementing appropriate preventive measures would do more to lower its incidence. METHODS: A prospective, randomized, open-label, long-term follow-up clinical trial was conducted to compare the efficacy of dressing the exit site with antibiotic ointment (AO) versus catheter antimicrobial locking (AL) in preventing catheter-related bacteremia (CRB), both associated with strict standard precautions and appropriate catheter care. A total of 141 tunneled catheters, newly implanted in 116 consecutive patients, were followed during a 2-year period. Patients were randomly distributed into one of three arms, with group A receiving AO prophylaxis, group B treated with a heparin + gentamicin (5.2 mg/ml) lock (AL) and group C receiving both AO and AL prophylaxis. RESULTS: Group A had a significantly lower infection-free time survival curve (p < 0.02, Kaplan-Meier) with a catheter survival of 103.9 days and a significantly higher number of CRB (9 episodes, p < 0.02, chi(2)). Group B had 130.7 mean infection-free days and 1 episode of CRB. Group C had 127.3 mean infection-free days and 5 episodes of CRB. No toxicity or other adverse events were observed during this 2-year period, and the efficacy of the preventive measures remained stable throughout. CONCLUSION: Antimicrobial lock is superior to AO as a CRB preventive measure. The use of lock and ointment in the same catheter was not associated with additive effects.
机译:背景:在确定的血管通路中使用隧道式血液透析导管正变得越来越普遍,在某些国家中,透析患者的比例达到了25%。使用导管时,感染的发病率和死亡率要比通过移植物或天然瘘管透析的患者高得多,并且普遍认为实施适当的预防措施可以降低其发生率。方法:进行了一项前瞻性,随机,开放标签的长期随访临床试验,以比较使用抗生素软膏(AO)和导管抗菌锁定(AL)敷设出口部位预防导管相关菌血症的疗效( CRB),均需遵守严格的标准预防措施和适当的导管护理。在2年的期间内,共对141例新近植入116例患者的隧道导管进行了随访。将患者随机分为三组之一,A组接受AO预防,B组接受肝素+庆大霉素(5.2 mg / ml)锁(AL)治疗,C组接受AO和AL预防。结果:A组的无感染时间生存曲线显着降低(p <0.02,Kaplan-Meier),导管生存时间为103.9天,CRB数量显着更高(9次发作,p <0.02,chi(2)) 。 B组平均无感染天数为130.7,CRB发作1次。 C组平均无感染天数为127.3天,CRB发作5次。在这两年期间未观察到毒性或其他不良事件,并且整个预防措施的效果保持稳定。结论:抗菌锁在预防CRB方面优于AO。在同一导管中使用锁和软膏与累加效应无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号